RECRUITING

A Text Messaging Intervention to Reduce Perinatal Depression Risk

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Development and preliminary testing of a text messaging intervention that will reduce the risk of a major depressive episode and worsening depressive symptoms in perinatal individuals. The system will screen pregnant individuals, send tailored text messages with links to enhanced content, and will include a peer chat function.This accessible text platform will leverage both the ease of use inherent in text messages and the power of enhanced content drawn evidence from based behavioral interventions (Interpersonal Therapy).

Official Title

A Text Messaging Intervention to Reduce Perinatal Depression Risk

Quick Facts

Study Start:2024-07-25
Study Completion:2025-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06117397

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:16 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * English speaking
  2. * "At risk" as determined by an Edinburgh Postnatal Depression Scale score of at least 9, or an average score \>3 on the 6-item Medical Outcomes Social Support Survey or history of depression in pregnancy or postpartum depression
  3. * At least age 16
  4. * Are willing and able to provide informed consent
  5. * Are willing to use a smart phone to receive texts
  1. * In a major depressive episode
  2. * Planning on terminating pregnancy
  3. * Have panic disorder or substance use disorder
  4. * Currently in behavioral health care treatment
  5. * Blind individuals
  6. * Permanently living in an institutional setting

Contacts and Locations

Study Contact

Kimberly Yonkers, MD
CONTACT
2034945055
kimberly.yonkers@umassmemorial.org
Katarzyna Pasciak, BS
CONTACT
9735708060
katarzyna.pasciak@umassmed.edu

Principal Investigator

Kimberly Yonkers, MD
PRINCIPAL_INVESTIGATOR
UMass Chan Medical School

Study Locations (Sites)

UMass Chan Medical School
Worcester, Massachusetts, 01655
United States

Collaborators and Investigators

Sponsor: University of Massachusetts, Worcester

  • Kimberly Yonkers, MD, PRINCIPAL_INVESTIGATOR, UMass Chan Medical School

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-25
Study Completion Date2025-12-01

Study Record Updates

Study Start Date2024-07-25
Study Completion Date2025-12-01

Terms related to this study

Additional Relevant MeSH Terms

  • Major Depressive Episode